Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and research offering highly sensitive mutation testing from plasma and serum samples. Our co...
Sysmex Inostics is a molecular diagnostics company that provides testing for physicians, clinical trials, and research offering highly sensitive mutation testing from plasma and serum samples. Our core competency in mutation discovery and detection uses technologies such as BEAMing Digital PCR and Plasma- Sequencing (Plasma-Seq). BEAMing and Plasma-Seq are the most sensitive technologies available today for detecting and discovering of tumor-specific somatic mutations. With our blood-based testing we deliver a non-invasive alternative for sensitive real-time molecular diagnostics to improve cancer detection, characterization and treatment. Our services include: • CLIA-certified laboratory in the US • Mutation testing based on BEAMing Digital PCR and Plasma-Seq for analyzing plasma/serum as well as tissue (frozen / FFPE) • Mutation assay development and validation • Kit development • Clinical trials testing (GCP) • Companion diagnostics development As "Inostics GmbH" the company was founded in September 2008 in Hamburg, Germany. Effective Oct 1st, Sysmex Corporation acquired all shares of the company (including its US subsidiary, Inostics Inc.). As a consequence, Inostics has changed its name to Sysmex Inostics GmbH and Sysmex Inostics Inc., and has become a wholly owned subsidiary of Sysmex Corporation.